OTC Markets OTCPK - Delayed Quote USD
Race Oncology Limited (RAONF)
1.2200
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 4.8M | 3M |
| Low Estimate | -- | -- | 4.8M | 3M |
| High Estimate | -- | -- | 4.8M | 3M |
| Year Ago Sales | -- | -- | 4M | 4.8M |
| Sales Growth (year/est) | -- | -- | 19.90% | -37.50% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RAONF | -- | -- | -- | -- |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Related Tickers
OTLC Oncotelic Therapeutics, Inc.
0.0600
+2.21%
RGBP Regen BioPharma, Inc.
0.0670
+15.43%
OKYO OKYO Pharma Limited
1.4500
-2.03%
THAR Tharimmune, Inc.
1.5100
+1.34%
GNLX Genelux Corporation
2.9600
+3.86%
IFRX InflaRx N.V.
1.6100
+1.90%
TVGN Tevogen Bio Holdings Inc.
1.0900
0.00%
NAGE Niagen Bioscience, Inc.
8.95
-3.14%
SRNE Sorrento Therapeutics, Inc.
0.0021
+90.91%
NWBO Northwest Biotherapeutics, Inc.
0.2800
+1.08%